Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 20, No. 1, 2007   

Free Abstract     Article (References)     Article (PDF 233 KB)     

Original Paper

In Search for New Antipsoriatic Agents: NAD+ Topical Composition
A. Wozniackaa, P. Szajerskib, J. Adamusb, J. Gebickib, A. Sysa-Jedrzejowskaa

aDepartment of Dermatology, Medical University, Lodz,
bInstitute of Applied Radiation Chemistry, Technical University, Lodz, Poland

Address of Corresponding Author

Skin Pharmacol Physiol 2007;20:37-42 (DOI: 10.1159/000096170)


 goto top of page Key Words

  • Nicotinamide adenine dinucleotide
  • Psoriasis
  • Antipsoriatic therapy

 goto top of page Abstract

The aim of the study was to examine the effectiveness of the oxidized form of nicotinamide adenine dinucleotide (NAD+), adenosine precursor, in 37 patients suffering from psoriasis. As NAD+ is known to be relatively unstable, the second goal was to establish the proper conditions for the satisfactory stability of topical NAD+ composition. In each patient, two matching plaques were selected for the study. Topical treatment with 1 or 0.3% NAD+ in Vaseline ointment administered twice daily was compared with overnight therapy with 0.1% anthralin applied for 12 h and placebo. The enzymatic method was applied to determine the stability of NAD+ in Vaseline ointment. After a 4-week application, the reduction in erythema, infiltration and desquamation caused by 1 or 0.3% topical NAD+ composition was similar to the reduction caused by 0.1% anthralin. It was demonstrated that NAD+ underwent a considerable decomposition at room temperature, while it was sufficiently stable at 5°C; thus, for a longer use the agent should be stored at fridge temperature. NAD+ therapy combines good efficacy, cosmetic acceptability and convenient twice-daily application.

Copyright © 2007 S. Karger AG, Basel


 goto top of page Author Contacts

Wozniacka Anna MD, PhD
Department of Dermatology, Medical University of Lodz
Krzemieniecka 5
PL-94-017 Lodz (Poland)
Tel./Fax +48 42 688 45 65, E-Mail wozniacka@bmp.net.pl


 goto top of page Article Information

Received: September 29, 2005
Accepted after revision: April 21, 2006
Published online: October 11, 2006
Number of Print Pages : 6
Number of Figures : 4, Number of Tables : 2, Number of References : 24

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17035720)
Download Citation
Cited In



This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues



For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel